Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Oncolytic vesicular stomatitis virus as a treatment for neuroendocrine tumors.

Surgery - 1 Dec 2013

Randle Reese W, Northrup Scott A, Sirintrapun S Joseph, Lyles Douglas S, Stewart John H

Abstract excerpt

BACKGROUND: Therapeutic goals for neuroendocrine tumors (NETs) not amenable to operative cure are limited to relieving symptoms and slowing progression. Many malignancies acquire defective antiviral responses as they undergo unregulated proliferation. Therefore, we explored the abilities of recombinant wild-type vesicular stomatitis virus and an attenuated matrix protein mutant (M51R-VSV) to exploit defective...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Line, Tumor
Share to Interferon-beta
Share to Mice, Nude

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Neuroendocrine Tumors

Share to Oncolytic Virotherapy

Share to Oncolytic Viruses

Share to Viral Matrix Proteins

Share to Xenograft Model Antitumor Assays

Source

Open in PubMed Open full text

Identifiers

PMID: 23973113
DOI: 10.1016/j.surg.2013.04.050
PMCID: PMC3833953

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Oncolytic vesicular stomatitis virus as a treatment for neuroendocrine tumors.PMID 23973113Read ↗

Vesicular stomatitis virus as a flexible platform for oncolytic virotherapy against cancerSemantic proximity Read ↗

Oncolytic Vesicular Stomatitis Virus: Optimisation Strategies for Anti-Cancer TherapiesSemantic proximity Read ↗

Evolution of Oncolytic Viruses: Novel Strategies for Cancer TreatmentSemantic proximity Read ↗

Virus–Receptor Interactions and Virus Neutralization: Insights for Oncolytic Virus DevelopmentSemantic proximity Read ↗

Oncolytic vaccinia virus GLV-1h68 exhibits profound antitumoral activities in cell lines originating from neuroendocrine neoplasmsSemantic proximity Read ↗

Immunovirotherapy Based on Recombinant Vesicular Stomatitis Virus: Where Are We?Semantic proximity Read ↗

VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents.Semantic proximity Read ↗

Oncolytic viruses: programmable tumour hunters.Semantic proximity Read ↗

Vesicular stomatitis virus: an exciting new therapeutic oncolytic virus candidate for cancer or just another chapter from Field's Virology?Semantic proximity Read ↗

Exploring Reovirus Plasticity for Improving Its Use as Oncolytic VirusSemantic proximity Read ↗

Employing RNA viruses to fight cancer: novel insights into oncolytic virotherapySemantic proximity Read ↗

The oncolytic virus ΔPK has multimodal anti-tumor activity.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.